Inqo Investments Ltd - Unaudited results for period ended 31 August 2024
Announcement provided by
Inqo Investments Limited · INQO27/11/2024 07:00
Unaudited Group Results for the half-year period ended 31 August 2024
CHAIRMAN AND CHIEF EXECUTIVE'S STATEMENT
Inqo Investments Limited ("Inqo" or "the Group") is a South African based social impact company that invests in businesses that tackle poverty and environmental challenges in Sub-Saharan Africa.
COMMENTARY
The Group remains in a strong financial position with total assets of R234,859,780 and minimal debt.
The results for the half-year period under review showed revenue of R8,199,813 (August 2023: R7,366,899). The hospitality and tourism industry is characterised by seasonal fluctuations, with the interim period aligning with the off-peak season, which historically results in lower occupancy rates and revenue. The Group generates 80% of its revenue from the hospitality and tourism sector. The Group earned a profit after tax of R532,516 (August 2023: loss after tax R4,069,070).
In April 2024, the company issued 1,854,646 new ordinary shares, raising gross capital of R 29,984,428. This includes the conversion of two credit loan notes of
In 2023, Inqo was awarded a
Whilst there has been no change in the company's shareholding in Spekboom Trading (Pty) Limited, a shift in the voting rights has occurred. As a result, the company has ceased consolidation and now recognises the investment under the equity method.
FINANCIAL INFORMATION
The financial information set out in this announcement does not constitute statutory financial statements. This financial information has been extracted from Inqo's unaudited group financial statements for the half-year period ended 31 August 2024.
FINANCIAL RESULTS
The unaudited financial results for the half-year period ended 31 August 2024 are as follows:
|
Aug-24 |
Aug-23 |
|
R'000 |
R'000 |
Revenue |
8,200 |
7,367 |
Profit/(Loss) for the year |
533 |
(4,069) |
Earnings per share |
0.03 |
(0.27) |
|
|
|
Total Assets |
234,860 |
223,854 |
|
|
|
Unutilised Grant Funding |
41,620 |
34,404 |
Total Liabilities excl Unutilised Grant Funding |
10,540 |
36,597 |
|
|
|
Net Assets |
182,700 |
152,853 |
Profit/(Loss) from operating activities includes the following items |
|
|
Grant income |
5,144 |
- |
Depreciation and amortisation |
(1,102) |
(1,605) |
Personnel Costs |
(2,524) |
(2,855) |
Directors' Fees and Salaries |
(648) |
(486) |
Listing Expenses |
(486) |
(373) |
Professional Fees |
(528) |
(307) |
Reversal/(Raising) of impairment of loans: Four One |
181 |
(25) |
Re-instatement of impairment of loans: Spekboom Trading |
(530) |
- |
Fair value adjustment of the buffalo herd |
18 |
296 |
In August 2024, the directors of Inqo reviewed the valuation placed on all income earning assets to ensure that they reflect their fair value. Following the reviews, the directors are of the view that Group assets as stated in the Statement of Financial Position are reflected at fair value. The only non-South African company where Inqo held investments that required assessment from a fair value adjustment perspective was Four One Financial Services Limited. The company has struggled financially but managed to remain operational, however in the process has defaulted on loan and interest repayments. For this reason, the loan including interest amounting to R4,005,264 remains impaired in full.
INVESTEE COMPANIES: FINANCIAL, ENVIRONMENTAL AND SOCIAL PERFORMANCE COMMENTARY
Beyond the specific changes outlined below, there have been no other material developments or significant events impacting the investee companies during the period.
Kuzuko Lodge (Pty) Limited (
After exiting the hotel management company approximately one year ago, Kuzuko Lodge has implemented a focused strategy to improve operational efficiency and increase revenue. These efforts have resulted in a turnaround, with a loss of R4,013,271 in August 2023 shifting to a loss of R743,774 in August 2024. This positive trajectory can be attributed to a combination of cost containment measures and targeted marketing initiatives. The directors anticipate that Kuzuko will continue to build on this momentum and achieve profitability by the end of the year, particularly as the peak tourism season approaches.
CARE Investees
· Flybox Budongo (BSF) Farm Limited (
· Pabidi Lodge Budongo Limited (
· Empower Clean Cooking Limited (
SUMMARY OF SOCIAL & ENVIRONMENTAL METRICS SINCE PROJECT COMMENCEMENT
· Kuzuko Lodge
o 35,617 acres (14,414 hectares) of former farmland restored and protected as a game reserve
o 70 km of game fencing erected
o 45 FTE staff at Kuzuko in standard housing with flush toilets, power, water and solar panels
o 120 fixed term jobs
o Conservation of 2 endangered species, 8 endangered species protected, 23 species introduced
o Re-wilded 18 adult cheetahs with diverse genetics to bolster the meta-population in southern
· Southlake Medical Centre
o 98,719 patient visits including 386 HIV patients receiving care and counselling, 5,599 people receiving health education including through community outreach, 217 safe deliveries, 205 surgeries, 2,000 cervical cancer screens and 700+ HPV vaccinations
· Kentegra
o 300 FTE and 26,000 contracted out-growers
· Sanergy
o 1,000 FTE, 2,000 indirect jobs, 5,000 toilets serving 270,000 people in
· Spekboom Trading
o 5,185 hectares degraded land planted with 30 million spekboom; 350 fixed term jobs
STAFF
The directors would like to take this opportunity to thank all the operating staff in the Group for their contribution and commitment to the Group's objectives during this challenging time.
K.S Tan R.H Steyn
Chairman Chief Financial Officer
Issued on: 27 November 2024
Enquiries
Inqo Investments Limited |
Tel: +27 834249880 |
Robyn Steyn, Chief Financial Officer |
Email: finance@inqo.co.za |
|
|
Hobart Capital Markets LLP |
|
AQSE Corporate Adviser and Broker |
Tel: +44 (0)20 7070 5665 |
Dr Wang Chong |
Email: wang.chong@hobartcapital.com |
Statements of Financial Position
Figures in R |
|
Group 31 August 2024 |
Group 29 February 2024 |
Group 31 August 2023 - restated* |
|
Assets |
|
|
|
|
|
Non-current assets Property, plant and equipment * |
|
150,695,290 |
151,980,926 |
152,842,048 |
|
Right-of-use assets |
|
|
68,147 |
152,975 |
|
Intangible assets |
|
339 |
840 |
1,340 |
|
Investment in joint ventures and associates |
|
7,867,661 |
|
|
|
Other investments |
|
7,179,889 |
7,306,227 |
9,134,004 |
|
Total non-current assets * |
|
165,743,179 |
159,356,140 |
162,130,367 |
|
Current assets |
|
|
|
|
|
Inventories |
|
4,179,170 |
4,295,937 |
5,055,693 |
|
Trade and other receivables |
|
3,550,837 |
6,059,424 |
3,858,133 |
|
Biological assets |
|
995,000 |
977,000 |
3,085,440 |
|
Cash and cash equivalents |
|
60,391,594 |
43,771,590 |
49,724,635 |
|
Total current assets |
|
69,116,601 |
55,103,951 |
61,723,901 |
|
Total assets * |
|
234,859,780 |
214,460,091 |
223,854,268 |
|
* - The donation of Spekboom plantings had been recognised as Other Income in the interim report for the period ended 31 August 2023. This was not the final accounting treatment in the audited annual financial statements for the year ended 29 February 2024, and as such the 31 August 2023 interim comparatives above have been corrected to follow the annual financial statements.
Figures in R |
|
|
Group 31 August 2024 |
Group 29 February 2024 |
Group 31 August 2023 - restated* |
|
Equity and liabilities |
|
|
|
|
|
|
Equity |
|
|
|
|
|
|
Ordinary share capital |
|
|
81,858,155 |
72,584,925 |
72,584,925 |
|
Share premium |
|
|
108,296,468 |
87,585,270 |
87,585,270 |
|
Accumulated loss * |
|
|
(94,528,411) |
(95,364,654) |
(94,049,312) |
|
Revaluation reserve |
|
|
86,693,347 |
86,693,347 |
86,693,347 |
|
Total equity attributable to owners of the parent* |
|
|
182,319,559 |
151,498,888 |
152,814,230 |
|
Non-controlling interests |
|
|
380,106 |
119,507 |
38,665 |
|
Total equity* |
|
|
182,699,665 |
151,618,395 |
152,852,895 |
|
Liabilities |
|
|
|
|
|
|
Non-current liabilities |
|
|
|
|
|
|
Deferred tax liabilities |
|
|
4,582,035 |
3,809,116 |
4,596,962 |
|
Loans from related parties |
|
|
1,614,127 |
3,423,672 |
4,599,458 |
|
Other loans |
|
|
|
18,931,500 |
18,590,000 |
|
Total non-current liabilities |
|
|
6,196,162 |
26,164,288 |
27,786,420 |
|
Current liabilities |
|
|
|
|
|
|
Trade and other payables |
|
|
4,344,165 |
3,683,554 |
8,061,296 |
|
Lease liabilities |
|
|
|
80,155 |
217,243 |
|
Unutilised grant funding |
|
|
41,619,788 |
32,846,571 |
34,404,005 |
|
Bank overdraft |
|
|
|
67,128 |
532,409 |
|
Total current liabilities |
|
|
45,963,953 |
36,677,408 |
43,214,953 |
|
Total liabilities |
|
|
52,160,115 |
62,841,696 |
71,001,373 |
|
Total equity and liabilities * |
|
|
234,859,780 |
214,460,091 |
223,854,268 |
|
Statements of Profit or Loss and Other Comprehensive Income
|
Group |
|
||
Group |
12 month |
Group 6 month |
||
6 month |
period ended |
period ended |
||
period ended |
29 February |
31 August 2023 |
||
Figures in R 31 August 2024 |
2024 |
- restated* |
||
Revenue |
|
8,199,813 |
20,610,801 |
7,366,899 |
Cost of sales |
|
(1,074,048) |
(2,421,823) |
(1,049,896) |
Gross profit |
|
7,125,765 |
18,188,978 |
6,317,003 |
Other income * |
|
5,378,999 |
3,630,200 |
279,996 |
Personnel expenses |
|
(3,171,797) |
(6,996,171) |
(3,340,548) |
Depreciation and amortisation |
|
(1,102,141) |
(2,936,964) |
(1,605,019) |
Listing expenses |
|
(486,185) |
(933,451) |
(372,904) |
Professional fees |
|
(528,209) |
(369,556) |
(306,600) |
Provision for doubtful debts |
|
(160,321) |
(319,841) |
(160,321) |
Impairment |
|
181,457 |
(1,920,552) |
(24,822) |
Reinstatement of loan impairment - Spekboom |
|
(530,286) |
|
|
Other expenses |
|
(5,966,543) |
(12,836,487) |
(6,511,330) |
Profit/ (loss) from operating activities * |
|
740,739 |
(4,493,844) |
(5,724,545) |
Inventory write (down)/up |
|
|
(832,272) |
8,000 |
Fair value adjustment |
|
18,000 |
(1,811,980) |
296,460 |
Finance income |
|
568,705 |
995,676 |
1,218,522 |
Finance costs |
|
(22,008) |
(167,020) |
(85,531) |
Profit/ (loss) before tax* |
|
1,305,436 |
(6,309,440) |
(4,287,094) |
Income tax (expense)/ credit |
|
(772,920) |
1,005,869 |
218,024 |
Profit/ (loss) for the period * |
|
532,516 |
(5,303,571) |
(4,069,070) |
|
|
|
Group |
|
|
Group |
|
12 month |
Group 6 month |
||
6 month |
|
period ended |
period ended |
||
period ended |
|
29 February |
31 August 2023 |
||
Figures in R |
|
31 August 2024 |
|
2024 |
- restated* |
Profit/ (loss} for the period attributable to: |
|
|
|
|
|
Owners of Parent * |
|
553,267 |
|
(5,262,858) |
(3,947,516) |
Non-controlling interest |
|
(20,751) |
|
(40,713) |
(121,554) |
|
|
532,516 |
|
(5,303,571} |
(4,069,070} |
Earnings per share from continuing and discontinuing operations |
|
|
|
|
|
attributable to owners of the parent during the period Basic earnings per share * Basic earnings/ (loss) per share * |
|
0.03 |
|
(0.36) |
(0.27) |
Diluted earnings per share * Diluted earnings/ (loss) per share * |
|
0.03 |
|
(0.36) |
(0.27) |
|
|
|
|
|
|
Total comprehensive income* |
|
532,516 |
|
(5,303,571} |
(4,069,070} |
Comprehensive income attributable to: |
|
|
|
|
|
Comprehensive income, attributable to owners of parent * |
|
553,267 |
|
(5,262,858) |
(3,947,516) |
Comprehensive income, attributable to non-controlling interests |
|
(20,751) |
|
(40,713) |
(121,554) |
|
|
532,516 |
|
(5,303,571} |
(4,069,070} |
Statement of Cash Flows
|
Group 6 month period ended |
|
Group 12 month period ended 29 February |
Group 6 month period ended |
||
Figures in R |
|
|
31 August 2024 |
|
2024 |
31 August 2023 |
Net cash flows used in operations |
|
|
(1,013,582) |
|
(11,800,817) |
(4,901,289) |
Interest paid |
|
|
(12,251) |
|
(143,656) |
(85,531) |
Interest received |
|
|
1,013,664 |
|
995,676 |
1,218,522 |
|
|
(12,169) |
|
(10,948,797) |
(3,768,298) |
|
Cash flows from investing activities |
|
|
|
|
|
|
Cash flows from losing control of subsidiaries |
|
|
(2,668) |
|
|
|
Cash flows used in obtaining control of subsidiaries or other businesses |
|
|
(7,225,997) |
|
|
|
Proceeds from sales of property, plant and equipment |
|
|
|
|
(17,103) |
58,696 |
Purchase of property, plant and equipment |
|
|
(746,289) |
|
(677,038) |
(300,055) |
Purchase of biological assets |
|
|
|
|
|
248,100 |
Purchase of other financial assets |
|
|
|
|
|
(141,170) |
Grant funding received |
|
|
17,728,014 |
|
1,397,799 |
17,066,111 |
Cash flows from investing activities |
|
|
9,753,060 |
|
703,658 |
16,931,682 |
Cash flows from financing activities |
|
|
|
|
|
|
Proceeds from issuing shares |
|
|
10,197,528 |
|
|
|
Other loans |
|
|
|
|
|
25,869 |
Payments to related parties |
|
|
227,105 |
|
(1,087,917) |
62,000 |
Loans received related parties |
|
|
|
|
17,786,900 |
|
Repayments of finance lease |
|
|
(80,155) |
|
(234,148) |
(82,284) |
|
|
10,344,478 |
|
16,464,835 |
5,585 |
|
Net increase in cash and cash equivalents before effect of |
|
|
|
|
|
|
exchange rate changes |
|
|
20,085,369 |
|
6,219,696 |
13,168,969 |
Effect of exchange rate changes on cash and cash equivalents |
|
|
(3,398,237) |
|
1,461,509 |
|
Net increase in cash and cash equivalents |
|
|
16,687,132 |
|
7,681,205 |
13,168,969 |
Cash and cash equivalents at beginning of the period |
|
|
43,704,462 |
|
36,023,257 |
36,023,257 |
Cash and cash equivalents at end of the period |
|
|
60,391,594 |
|
43,704,462 |
49,192,226 |
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.